Citation data

OpenAlex

Works that cite this article, indexed by OpenAlex.

59 resultsUpdated October 25, 2026

← Back to article

Nonalcoholic fatty liver disease: A comprehensive review of a growing epidemic

World Journal of Gastroenterology 20(34) (2014)

Kareem Hassan

Efficacy and safety of anti-hyperglycaemic drugs in patients with non-alcoholic fatty liver disease with or without diabetes: An updated systematic review of randomized controlled trials

Diabetes & Metabolism 46(6) (2020)

Alessandro Mantovani; Christopher D. Byrne; Eleonora Scorletti; Christos Socrates Mantzoros; Giovanni Targher

Rates of and Factors Associated With Placebo Response in Trials of Pharmacotherapies for Nonalcoholic Steatohepatitis: Systematic Review and Meta-analysis

Clinical Gastroenterology and Hepatology 17(4) (2018)

Ma Ai Thanda Han; Osama Altayar; Shadi Hamdeh; Varun K. Takyar; Yaron Rotman; Ohad Etzion; Eric A Lefebvre; Rifaat Safadi; Vlad Ratziu; Larry J. Prokop; Mohammad Hassan Murad; Mazen Noureddin

Effect of canagliflozin on liver function tests in patients with type 2 diabetes

Diabetes & Metabolism 42(1) (2015)

Lawrence A. Leiter; Thomas M. Forst; David Polidori; Dainius A. Balis; John Xie; Sue Sha

Pharmacological treatment and therapeutic perspectives of metabolic syndrome

Reviews in Endocrine and Metabolic Disorders 15(4) (2014)

Soo Kyung Lim; Robert H. Eckel

Nonalcoholic Fatty Liver Disease (NAFLD) as Model of Gut–Liver Axis Interaction: From Pathophysiology to Potential Target of Treatment for Personalized Therapy

International Journal of Molecular Sciences 22(12) (2021)

Francesca Fianchi; Antonio Liguori; Antonio Gasbarrini; Antonio Grieco; Luca Miele

Pharmacological interventions for non-alcohol related fatty liver disease (NAFLD)

Cochrane Database of Systematic Reviews 2017(4) (2017)

Rosa Lombardi; Simona Onali; Douglas Thorburn; Brian Ritchie Davidson; Kurinchi Selvan Gurusamy; Emmanuel A. Tsochatzis

Diabetes drugs for nonalcoholic fatty liver disease: a systematic review

Systematic Reviews 8(1) (2019)

Ian Blazina; Shelley Selph

Antidiabetic drugs and non-alcoholic fatty liver disease: A systematic review, meta-analysis and evidence map

Digestive and Liver Disease 53(1) (2020)

Jai Kumar; Roha Saeed Memon; Izza Shahid; Tehlil Rizwan; Maryam Zaman; Ritesh George Menezes; Sarwan Kumar; Tariq Jamal Siddiqi; Muhammad Usman

The Role of Transcription Factor PPAR-γ in the Pathogenesis of Psoriasis, Skin Cells, and Immune Cells

International Journal of Molecular Sciences 23(17) (2022)

Vladimir Vasilievich Sobolev; Ekaterina Tchepourina; Irina Markovna Korsunskaya; Natalia Anatolievna Geppe; Svetlana Nikolaevna Chebysheva; Anna Gennadievna Soboleva; Alexandre Mezentsev

Non-alcoholic fatty liver disease in adults 2021: A clinical practice guideline of the Italian Association for the Study of the Liver (AISF), the Italian Society of Diabetology (SID) and the Italian Society of Obesity (SIO)

Nutrition Metabolism and Cardiovascular Diseases 32(1) (2021)

Giulio Marchesini; Elisabetta Bugianesi; Patrizia Burra; Fabio Marra; Luca Miele; Anna Alisi; Piero Vajro; Mario Masarone; Salvatore Petta; Marcello Persico; Gianluca Svegliati‐Baroni; Luca V. C. Valenti; Massimo Federici; Francesco Purrello; Ferdinando Carlo Sasso; Giovanni Targher; Luca Busetto; Maria Letizia Petroni; Ferruccio Santini; Calogero Cammà; Agostino Colli

The role of anti-diabetic drugs in NAFLD. Have we found the Holy Grail? A narrative review

European Journal of Clinical Pharmacology 80(1) (2023)

Maria Zachou; Pagona Flevari; Narjes Nasiri Ansari; Constantinos Varytimiadis; Evangelos Kalaitzakis; Eva N. Kassi; Θεόδωρος Ανδρουτσάκος

The impact of metformin on weight and metabolic parameters in patients with obesity: A systematic review and meta‐analysis of randomized controlled trials

Diabetes Obesity and Metabolism 26(5) (2024)

Rachelle Haber; Fatima Zarzour; Malak Ghezzawi; Natalie Saadeh; Dania S. Bacha; Lama Al Jebbawi; Marlene Chakhtoura; Christos Socrates Mantzoros

Prediction of Nonalcoholic Fatty Liver Disease Via a Novel Panel of Serum Adipokines

Medicine 95(5) (2016)

Raika Jamali; Abbas Arj; Mohsen Razavizade; Mohammad Hossein Aarabi

Peroxisome Proliferator Activator Receptor (PPAR)-γLigand, but Not PPAR-α, Ameliorates Cyclophosphamide-Induced Oxidative Stress and Inflammation in Rat Liver

PPAR Research 2014 (2014)

Azza A. K. El‐Sheikh; Rehab Ahmed Rifaai

Serum adipokines might predict liver histology findings in non-alcoholic fatty liver disease

World Journal of Gastroenterology 22(21) (2016)

Raika Jamali; Mohsen Razavizade; Abbas Arj; Mohammad Hossein Aarabi

The Effect of Berberis Vulgaris Extract on Transaminase Activities in Non-Alcoholic Fatty Liver Disease

Hepatitis Monthly 15(2) (2015)

Raziyeh Illon Kashkooli; Seyed Saeed Najafi; Farkhondeh Sharif; Azadeh Hamedi; Mohammad Kazem Hosseini Asl; Majid Najafi Kalyani; Mehdi Birjandi

Levocetirizine ameliorates high fructose diet-induced insulin resistance, vascular dysfunction and hepatic steatosis in rats

European Journal of Pharmacology 740 (2014)

Noha M. Shawky; George S.G. Shehatou; Mona Abdel Rahim; Ghada Mohamed Suddek; Nariman M. Gameil

The effect of pioglitazone on weight, lipid profile and liver enzymes in type 2 diabetic patients

Therapeutic Advances in Endocrinology and Metabolism 6(2) (2015)

Naser Aghamohammadzadeh; Mitra Niafar; Elham Dalir Abdollahinia; Farzad Najafipour; Saeed Mohammadzadeh Gharebaghi; Khadijeh Adabi; Elaheh Dalir Abdolahinia; Hamidreza Ahadi

Comparison of the effects of sulforaphane and pioglitazone on insulin resistance and associated dyslipidemia, hepatosteatosis, and endothelial dysfunction in fructose-fed rats

Environmental Toxicology and Pharmacology 66 (2018)

Noha M. Shawky; George S.G. Shehatou; Ghada Mohamed Suddek; Nariman M. Gameil

Improvement of Insulin Sensitivity Increases Pregnancy Rate in Infertile PCOS Women: A Systemic Review

Frontiers in Endocrinology 12 (2021)

Yuqi Liu; Juan Li; Zhe Yan; Dan Liu; Jinfang Ma; Nanwei Tong

Non-alcoholic fatty liver disease in adults 2021: A clinical practice guideline of the Italian Association for the Study of the Liver (AISF), the Italian Society of Diabetology (SID) and the Italian Society of Obesity (SIO)

Digestive and Liver Disease 54(2) (2021)

Efficacy of Various Hypoglycemic Agents in the Treatment of Patients With Nonalcoholic Liver Disease With or Without Diabetes： A Network Meta-Analysis

Frontiers in Endocrinology 12 (2021)

Jingxuan Lian; Jianfang Fu

Optimized strategy among diet, exercise, and pharmacological interventions for nonalcoholic fatty liver disease: A network meta‐analysis of randomized controlled trials

Obesity Reviews 25(6) (2024)

Hao Wang; Qianqian Ma; Youpeng Chen; Ling Luo; Junzhao Ye; Bihui Zhong

Efficacy of Hypoglycemic Agents in Metabolic Dysfunction Associated Steatotic Liver Disease (MASLD): A Systematic Review and Network Meta‐Analysis

Journal of Evidence-Based Medicine 18(2) (2025)

Qiao Ren; Yao Tan; Guixiang Zhang; Yuzhao Dai; Lidan Yang; Yunmo Wu; He He; Jie Chen

Mechanism of action and effect of immune-modulating agents in the treatment of psoriasis

Biomedicine & Pharmacotherapy 85 (2016)

Rehab M. Elgharabawy; Amira Saber Ahmed; Amal Hassan Al-Najjar

Fatty Liver Index (FLI) in Predicting Non-alcoholic Fatty Liver Disease (NAFLD)

Hepatitis Monthly 18(2) (2018)

Zahra Dehnavi; Farkhondeh Razmpour; Mahmoud Belghaisi Naseri; Mohsen Nematy; Seyed Ali Alamdaran; Hassan Vatanparast; Mohsen Azimi–Nezhad; Bita Abbasi; Azita Ganji

Data on Adiponectin from 2010 to 2020: Therapeutic Target and Prognostic Factor for Liver Diseases?

International Journal of Molecular Sciences 21(15) (2020)

Misaq Heydari; María Eugenia Cornide‐Petronio; Mónica B. Jiménez‐Castro; Carmen Peralta

Pharmacological interventions for non-alcoholic fatty liver disease: a systematic review and network meta-analysis

Postgraduate Medical Journal 94(1116) (2018)

Kannan Sridharan; Gowri Sivaramakrishnan; Reginald Paul Sequeira; Abdelaziz Elamin

Non-alcoholic fatty liver disease in adults 2021: A clinical practice guideline of the Italian Association for the Study of the Liver (AISF), the Italian Society of Diabetology (SID) and the Italian Society of Obesity (SIO)

Eating and Weight Disorders - Studies on Anorexia Bulimia and Obesity 27(5) (2021)

Associazione Italiana per lo Studio del Fegato (AISF), Società Italiana di Diabetologia (SID) and Società Italiana dell’Obesità (SIO)

The Correlation between Serum Zinc Level and Liver Histology in Non-Alcoholic Steatohepatitis

Iranian journal of pathology 14(1) (2018)

Farid Kosari

Dietary Determinants of Non-Alcoholic Fatty Liver Disease in Lean and Non-Lean Adult Patients: A Population-Based Study in Shiraz, Southern Iran

Hepatitis Monthly 17(4) (2017)

Behnam Honarvar; Kamran Bagheri Lankarani; Parisa Keshani; Tayebe Rafiee

Sodium-glucose cotransporter protein-2 inhibitors and glucagon-like peptide-1 receptor agonists versus thiazolidinediones for non-alcoholic fatty liver disease: A network meta-analysis

Acta Diabetologica 59(4) (2022)

Chen Ding; Yaxin Tang; Wenqiang Zhu; Piaopiao Huang; Pingan Lian; Juanli Ran; Xiansheng Huang

Amelioration of High Fructose Diet-Induced Insulin Resistance, Hyperuricemia, and Liver Oxidative Stress by Combined Use of Selective Agonists of PPAR-α and PPAR-γ in Rats

Dubai Medical Journal 3(2) (2020)

Mahmoud M. Farag; Ehab H. Ashour; Wessam Fahmy El-Hadidy

Pioglitazone for the Treatment of Metabolic-Associated Fatty Liver Disease in People Living With HIV and Prediabetes

Cureus 13(10) (2021)

Sarunporn Kamolvisit; Supphamat Chirnaksorn; Hataikarn Nimitphong; Somnuek Sungkanuparph M. D

Comparative efficacy of diabetes medications on liver enzymes and fat fraction in patients with nonalcoholic fatty liver disease: A network meta-analysis,,

Clinics and Research in Hepatology and Gastroenterology 47(1) (2022)

Caiyan Zou; Yan Sun; Jun Liang

Potential Approaches to Ameliorate Hepatic Fat Accumulation Seen with MTP Inhibition

Drug Safety 37(4) (2014)

Minjie Lin; Shui‐Ping Zhao; Li Shen; Danyan Xu

How Does Addition of Regular Aerobic Exercises, Influence the Efficacy of Calorie-Restricted Diet in Patients with Non-Alcoholic Steatohepatatis (NASH)?

Hepatitis Monthly 17(5) (2017)

Hossein Nikroo; Mohsen Nematy; Seyyed Reza Attarzadeh Hosseini; Hamid Reza Sima; Farkhondeh Razmpour

The Evaluation of Effective Drugs for the Treatment of Non-Alcoholic Fatty Liver Disease: A Aystematic Review and Network Meta-Analysis

Advanced Pharmaceutical Bulletin 10(4) (2020)

Ramin Jalili; Mohammad Hossein Somi; Hossein Hosseinifard; Fatemeh Salehnia; Morteza Ghojazadeh; Nima Makhdami; Masoud Shirmohammadi

Which Metabolic Index is Appropriate for Predicting Non-alcoholic Steatohepatitis?

Middle East Journal of Digestive Diseases 12(2) (2020)

Raika Jamali; Mehdi Ebrahimi; Ali Faryabi; Haleh Ashraf

Cardiovascular protective effects of PPARγ agonists in hypothyroid rats: protection against oxidative stress

Clinical and Experimental Hypertension 44(6) (2022)

Yousef Baghcheghi; Farimah Beheshti; Mahmoud Hosseini; Arezoo Gowhari Shabgah; Mohammad Ali‐Hassanzadeh; Mahdiyeh Hedayati‐Moghadam

The Effects of Helicobacter Pylori Eradication on Liver Function and Metabolic Profile in Non-diabetic Non-alcoholic Steatohepatitis: A 5-year Randomized Clinical Trial

Middle East Journal of Digestive Diseases 14(1) (2022)

Arsia Jamali; Shahrokh Karbalai Saleh; Ghazale Tefagh; Raika Jamali; Ayat Ahmadi

Pluchea indica Leaf Extract Alleviates Dyslipidemia and Hepatic Steatosis by Modifying the Expression of Lipid Metabolism-Related Genes in Rats Fed a High Fat-High Fructose Diet

Preventive Nutrition and Food Science 27(4) (2022)

Patcharin Singdam; Jarinyaporn Naowaboot; Laddawan Senggunprai; Kampeebhorn Boonloh; Patchareewan Pannangpetch

Evaluation of PEN2-ATP6AP1 axis as an antiparasitic target for metformin based on phylogeny analysis and molecular docking

Molecular and Biochemical Parasitology 255 (2023)

Congshan Liu; Shangrui Zhang; Jian Xue; Haobing Zhang; Jianhai Yin

Liver fat content might be an appropriate measure for estimation of cardiovascular disease risk in non-alcoholic steatohepatitis patients

Medical Journal of the Islamic Republic of Iran 34 (2020)

Raika Jamali; Saeed Pourhassan; Nastaran Maghbooli; Haleh Ashraf; Amir Ali Sohrabpour

Relationship Between Cardiovascular Disease Risk Factors and Quality of Life in Patients with Metabolic-Associated Fatty Liver Disease

Hepatitis Monthly 22(1) (2022)

Raika Jamali; Soroush Veisi; Arsia Jamali; Mehdi Yaseri

Protein analysis of rat hepatocytes under conditions glutamate-induced obesity and its correction

Bulletin of Taras Shevchenko National University of Kyiv Series “Psychology” 70(2) (2015)

D. Voieikova; L. I. Stepanova; О. Savchuk; Л. І. Остапченко; М. М. Кондро

Pioglitazone versus metformin in Egyptian non diabetic patients with Non Alcholic Fatty Liver Disease: A randomized controlled trial.

IOSR Journal of Pharmacy (IOSRPHR) 07(05) (2017)

Sahar K. Hgazy; Mamdouh Ahmed Gabr; Nahla E. El‐Ashmawy; Maha A. Younis

The effects of pioglitazone and rosiglitazone on liver function in hypothyroid rats

Journal of Complementary and Integrative Medicine 21(1) (2024)

Yousef Baghcheghi; Farimah Beheshti; Fatemeh Seyedi; Mahdiyeh Hedayati‐Moghadam; Hedyeh Askarpour; Aliasghar Kheirkhah; Ahmad Golkar; Mohammad Dalfardi; Mahmoud Hosseini

Research Progress of the Prevention and Treatment of Metabolic Associated Fatty Liver Disease as a Complication Disease of Endocrine Therapy for Breast Cancer

Advances in Clinical Medicine 15(03) (2025)

胜鹏覃

The association between liver function tests abnormalities and type 2 diabetes mellitus patients in Saudi Arabia: a cross-sectional study

Frontiers in Clinical Diabetes and Healthcare 6 (2025)

Nimer Mehyar; Ziyad Alhajeri; Muath Alosaimi; Ziyad Alanazi; Abdulkarim Alanazi; Raghib Abu-Saris